Xu Jiandong
CIK 0001920399
Chief Financial Officer10% Owner
Filings
5
Latest Apr 29, 2026
Issuers covered
2
Showing
5 of 5
Page 1
Track record
3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +88.0% | +100.9% | +119.0% | +44.2% |
| 90 days | 3 | 100% | +45.8% | +31.9% | +100.0% | +5.6% |
| 180 days | 3 | 67% | +4.4% | +7.9% | +17.3% | -12.1% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Xu Jiandong has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DECA | Denali Capital Acquisition Corp. | 3 | Sep 16, 2024 |
| ESLA | Estrella Immunopharma, Inc. | 2 | Apr 29, 2026 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|